In the placebo session, lipid peroxidation was increased in response to MS (baseline, 4.97±1.02 nmol/mL vs MS, 6.06±1.95 nmol/mL, P<0.02; placebo, 6.06±1.95 nmol/mL vs AT1R blockade, 1.08±0.43 nmol/mL, P<0.01; placebo, 6.06±1.95 nmol/mL vs AA, 4.74±1.21 nmol/mL, P<0.01) but greatly decreased 60 min after (baseline, 4.97±1.02 nmol/mL vs 60MS, 4.01±0.99 nmol/mL, P<0.03; MS, 6.06±1.95 nmol/mL vs 60MS, 4.01±0.99 nmol/mL, P<0.01). Here, AGTR1 is linked to myeloid sarcoma.